pre-IPO PHARMA

COMPANY OVERVIEW

Blaze Bioscience, Inc. is a privately held biotechnology company focused on guided therapies.


LOCATION

  • Seattle, WA, USA

  • THERAPEUTIC AREAS

  • Oncology

  • WEBSITE

    https://www.blazebioscience.com/


    CAREER WEBSITE

    https://www.blazebioscience.com/careers.html


    SOCIAL MEDIA


    INVESTORS



    PRESS RELEASES


    Nov 2, 2022

    Blaze Bioscience Announces Enrollment is Complete on its Pivotal Phase 2/3 Trial of tozuleristide and the CanvasTM Imaging System in Pediatric Central Nervous System Tumors


    Apr 7, 2020

    Blaze Bioscience Announces FDA Has Granted Fast Track Designation to BLZ-100 (tozuleristide) for Pediatric Central Nervous System Tumors


    May 9, 2019

    Blaze Bioscience Announces the Publication of Phase 1 Clinical Trial Results for Tumor Paint: BLZ-100 (tozuleristide) in Adults with Glioma


    Nov 28, 2018

    CORRECTING and REPLACING Blaze Bioscience Announces the Initiation of Pivotal Clinical Trial for Tumor Paint: BLZ-100 (tozuleristide) and the Canvas Imaging System


    Mar 28, 2017

    Blaze Bioscience Announces Tumor Paint BLZ-100 Publication in International Journal of Toxicology


    For More Press Releases


    Google Analytics Alternative